파이프라인

Comprehensive Pipeline

Pipeline Product Candidate Non-Clinical Phase 1 Phase 2 Phase 3
Targeted Therapy Rivoceranib (VEGFR-2)
Gastric Cancer 3rd Line

IO combination P I/II

CRC 3rd line

GC 2nd lin P I/II

LSK 9985 (BTK/JAK3 Inhibitor)
Leukemia/Autoimmune disease

SP - 2577 (LSD1)
Solid Tumor / Leukemia

Tegavivint (WNT/B-catenin)
Solid Tumor / Leukemia

Cell Therapy LifeLiver (Bioartificial Liver)
Acute Liver Failure

HepaStem (Liver)
Urea Cycle Disorder

Nonalcoholic Stratohepatitis (F.U.)

Medical Device LL - 2000 / LL - 1000
Surgical Hemostat